137 related articles for article (PubMed ID: 9284857)
1. Role of duration of diuretic effect in preventing sodium retention.
Ferguson JA; Sundblad KJ; Becker PK; Gorski JC; Rudy DW; Brater DC
Clin Pharmacol Ther; 1997 Aug; 62(2):203-8. PubMed ID: 9284857
[TBL] [Abstract][Full Text] [Related]
2. Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure.
Pivac N; Rumboldt Z; Sardelić S; Bagatin J; Polić S; Ljutić D; Naranca M; Capkun V
Int J Clin Pharmacol Res; 1998; 18(3):121-8. PubMed ID: 9825268
[TBL] [Abstract][Full Text] [Related]
3. Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion.
Dormans TP; van Meyel JJ; Gerlag PG; Tan Y; Russel FG; Smits P
J Am Coll Cardiol; 1996 Aug; 28(2):376-82. PubMed ID: 8800113
[TBL] [Abstract][Full Text] [Related]
4. Dose-ranging evaluation of bumetanide pharmacodynamics in critically ill infants.
Sullivan JE; Witte MK; Yamashita TS; Myers CM; Blumer JL
Clin Pharmacol Ther; 1996 Oct; 60(4):424-34. PubMed ID: 8873690
[TBL] [Abstract][Full Text] [Related]
5. [Effect of posture on the diuretic treatment of decompensated cirrhosis and heart failure].
Wilken-Jensen C; Ring-Larsen H; Henriksen JH; Clausen J; Pals H; Christensen NJ
Ugeskr Laeger; 1989 Jan; 151(1):13-5. PubMed ID: 2911877
[TBL] [Abstract][Full Text] [Related]
6. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
Sanjay S; Annigeri RA; Seshadri R; Rao BS; Prakash KC; Mani MK
Nephrology (Carlton); 2008 Jun; 13(3):247-50. PubMed ID: 18315706
[TBL] [Abstract][Full Text] [Related]
7. Loop diuretics for chronic renal insufficiency: a continuous infusion is more efficacious than bolus therapy.
Rudy DW; Voelker JR; Greene PK; Esparza FA; Brater DC
Ann Intern Med; 1991 Sep; 115(5):360-6. PubMed ID: 1863026
[TBL] [Abstract][Full Text] [Related]
8. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
9. Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD.
Costanzo MR; Saltzberg MT; Jessup M; Teerlink JR; Sobotka PA;
J Card Fail; 2010 Apr; 16(4):277-84. PubMed ID: 20350693
[TBL] [Abstract][Full Text] [Related]
10. [Bumetanide in renal insufficiency].
Humair L
Schweiz Med Wochenschr; 1982 Feb; 112(9):310-4. PubMed ID: 7079713
[TBL] [Abstract][Full Text] [Related]
11. Bumetanide continuous infusions in critically ill pediatric patients.
McCallister KM; Chhim RF; Briceno-Medina M; Shelton CM; Figueroa M; Rayburn M
Pediatr Crit Care Med; 2015 Feb; 16(2):e19-22. PubMed ID: 25560424
[TBL] [Abstract][Full Text] [Related]
12. Renal tubular resistance is the primary driver for loop diuretic resistance in acute heart failure.
Ter Maaten JM; Rao VS; Hanberg JS; Perry Wilson F; Bellumkonda L; Assefa M; Sam Broughton J; D'Ambrosi J; Wilson Tang WH; Damman K; Voors AA; Ellison DH; Testani JM
Eur J Heart Fail; 2017 Aug; 19(8):1014-1022. PubMed ID: 28105769
[TBL] [Abstract][Full Text] [Related]
13. Urinary composition during decongestive treatment in heart failure with reduced ejection fraction.
Verbrugge FH; Nijst P; Dupont M; Penders J; Tang WH; Mullens W
Circ Heart Fail; 2014 Sep; 7(5):766-72. PubMed ID: 25037309
[TBL] [Abstract][Full Text] [Related]
14. Study of the sites and mechanisms of action of bumetanide in man.
Jayakumar S; Puschett JB
J Pharmacol Exp Ther; 1977 Apr; 201(1):251-8. PubMed ID: 850144
[TBL] [Abstract][Full Text] [Related]
15. Rapid and Highly Accurate Prediction of Poor Loop Diuretic Natriuretic Response in Patients With Heart Failure.
Testani JM; Hanberg JS; Cheng S; Rao V; Onyebeke C; Laur O; Kula A; Chen M; Wilson FP; Darlington A; Bellumkonda L; Jacoby D; Tang WH; Parikh CR
Circ Heart Fail; 2016 Jan; 9(1):e002370. PubMed ID: 26721915
[TBL] [Abstract][Full Text] [Related]
16. The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance.
Givertz MM; Massie BM; Fields TK; Pearson LL; Dittrich HC;
J Am Coll Cardiol; 2007 Oct; 50(16):1551-60. PubMed ID: 17936154
[TBL] [Abstract][Full Text] [Related]
17. The effect of continuous infusion loop diuretics in patients with acute decompensated heart failure with hypoalbuminemia.
Bleske BE; Clark MM; Wu AH; Dorsch MP
J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):334-7. PubMed ID: 23424098
[TBL] [Abstract][Full Text] [Related]
18. [Recombinant human brain natriuretic peptide on the cardiac hemodynamics and renal function in dogs with heart failure].
Xu XW; Zeng GY; Yang Y; Liu HX
Yao Xue Xue Bao; 2002 Oct; 37(10):758-62. PubMed ID: 12567856
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of conivaptan hydrochloride, a vasopressin V(1A)/V(2)-receptor antagonist, in patients with euvolemic or hypervolemic hyponatremia and with or without congestive heart failure from a prospective, 4-day open-label study.
Mao ZL; Stalker D; Keirns J
Clin Ther; 2009 Jul; 31(7):1542-50. PubMed ID: 19695403
[TBL] [Abstract][Full Text] [Related]
20. Effect of nesiritide infusion duration on renal function in acutely decompensated heart failure patients.
Chow SL; Peng JT; Okamoto MP; Heywood JT
Ann Pharmacother; 2007 Apr; 41(4):556-61. PubMed ID: 17389662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
